An assay system employing radiolabeled, heat-killed Streptococcus pneumoniae and human polymorphonuclear leukocytes was utilized to study serum pneumococcal opsonic requirements. Comparing the kinetics of phagocytosis in normal serum, heat-inactivated serum, immunoglobulin G (IgG)-deficient serum, C2-deficient serum, and magnesium dichloride ethyleneglycol-tetraacetic acid (MgEGTA)-chelated serum allowed definition of the opsonic requirements for four pneumococcal serotypes: VI, XVIII, XXIII, and XXV. All four serotypes were efficiently opsonized in 10% normal serum. Only type XVIII was opsonized in heat-inactivated serum. All four were also opsonized in IgG-deficient serum but not as efficiently as in normal serum. Opsonization via the alternative pathway was diminished for all four serotypes in 10% MgEGTA-chelated and C2-deficient serum. Furthermore, by varying the concentration of MgEGTAchelated serum, it was found that type XXV was least efficiently opsonized via the alternative pathway. The quantitative nature of this assay system will permit measurement of bacterial and host factors that may contribute to host susceptibility to pneumococcal infection.
Optimal phagocytosis and subsequent intracellular killing of most bacteria, including Streptococcus pneumoniae, require the participation of opsonins, including serum complement and immunoglobulin (Ig). Employing rabbit serum, Johnston et al. showed that the opsonic activity of hyperimmune serum was amplified by complement, whereas opsonization in nonimmune serum was primarily mediated by complement (12) . Human antibodies against pneumococcal capsular polysaccharide apparently do not fix complement via the classical complement pathway (10, 21) . More recently, experiments have shown that an opsonically active fragment (C3b) can be generated by complement activation via the alternative pathway in the absence of specific antibody (11, 25) .
Employing an assay that measured complement consumption via alternative pathway activation, Fine described three distinct patterns of pneumococcal opsonization: (i) C3 activation via the alternative pathway in the absence of antibody (types VII, XII, XIV, and XXV), (ii) C3 activation via the alternative pathway only in the presence of specific antibody (types III, IV, and VIII), and (iii) failure to activate C3 via the alternative pathway even in the presence of specific antibody (type I) (6) . He suggested a relationship between virulence and the pattern t Present address: Microbiology Laboratory, Catharijnesingel 59, Utrecht, The Netherlands. of opsonization for each serotype. However, seven of the eight types tested are invasive and are frequently recovered from patients with bacteremic infections (1, 13, 15) . It would be of interest to compare the opsonic requirements of pneumococcal types that rarely cause bacteremic disease with the commonly recovered types. Fine (6) and Winkelstein et al. (27) were unable to show a difference between noncapsulated and capsulated varients of single serotypes in their degree of complement consumption. Since others have demonstrated the type specificity of the M protein antigen of pneumococcus (2) and the heterogeneity of both capsular and C polysaccharides among pneumococcal strains (19) , it is possible that these mucopeptide moieties also determine pneumococcal opsonic requirements.
In this report, pneumococcal opsonic requirements in human serum were directly studied by a sensitive, functional assay. Polymorphonuclear (PMN) leukocyte uptake of heat-killed [3H]thymidine-labeled pneumococci, preopsonized in human serum, was measured. The opsonic capacities of normal, heat-inactivated, and IgGdeficient sera were studied. Alternative complement pathway opsonization was assessed in serum chelated with magnesium dichloride ethyleneglycol-tetraacetic acid (MgEGTA) and in human C2-deficient serum. Serum chelated with MgEGTA has been shown by others to support alternative but not classical complement pathway function (7) . Normal serum was compared with these selectively deficient sera to determine the contribution of different heat-stable and heat-labile serum factors to the phagocytosis of S. pneumoniae. The opsonic requirements of type VI, XVIII, XXIII, and XXV pneumococci were studied, representing both lower-and higher-numbered serotypes frequently isolated from children with pneumococcal otitis media (20) .
MATERIALS AND METHODS Pneumococci. S. pneumoniae types XVIII, XXIII, and XXV were isolated from children with pneumococcal bacteremia; type VI was obtained from the American Type Culture Collection (Rockville, Md.). Serotypes were confirmed with type-specific antisera (Statens Seruminstitut, Copenhagen, Denmark). Virulent, encapsulated organisms were maintained by mouse passage every 2 to 4 weeks. Several colonies of bacteria were inoculated from sheep blood agar plates into 10 Leukocytes. Blood was drawn from healthy adult donors into a heparinized syringe (10 U of heparin per ml). One-third volume of 6% dextran (Cutter Laboratories, Berkeley, Calif.) was added, and the mixture was allowed to settle at room temperature for 1 h. The leukocyte-rich plasma was removed and centrifuged at 150 x g for 5 min. The leukocyte pellet was washed twice in heparinized saline (10 U of heparin per 10 ml of saline). Bacterial opsonization. To eliminate the inhibitory effect of cation depletion on phagocytosis during the study of MgEGTA-chelated serum (23) , and to remove factors in heat-inactivated serum that might adversely affect phagocytosis (9), bacteria were first incubated with each opsonic source; they were then centrifuged, the supernatant was discarded, and leukocytes were added. Specifically, 0.4 ml of the desired opsonin was added to a plastic tube (12 by 75 mm; Falcon Plastics, Oxnard, Calif.) that contained 0.1 ml of radiolabeled, heat-killed pneumococci at 2.5 x 102'/ml. After 30 min of incubation at 37°C, the mixture was centrifuged at 1,600 xgfor 15 min. The supematant was discarded, and the bacterial pellet was suspended in 0.4 ml of gel-HBSS. The kinetics of opsonization were evaluated by incubating pneumococci with opsonin for 5, 15, and 30 min before phagocytes were added. In one series of experiments opsonization of live and of heat-killed pneumococci were compared.
Phagocytosis mixture. The phagocytosis mixtures consisted of 0.5 ml of the opsonized bacteria (suspended in gel-HBSS) and 0. Type XXIII pneumococci were more efficiently opsonized in 10% normal serum than the other serotypes; 70% were phagocytized after 30 min of incubation (Fig. lc) . No appreciable phagocytosis was observed after opsonization in either heat-inactivated serum or C2-deficient serum. There was slight opsonic activity in IgGdeficient serum and in chelated serum, but phagocytosis was only 20% of that observed when this serotype was opsonized in normal serum.
There was efficient phagocytosis of type XXV pneumococci opsonized in 10% normal serum, whereas IgG-deficient serum provided approximately one-half the opsonic activity of normal serum (Fig. ld) (Fig. 2) . Twenty percent normal serum provided as much opsonic activity as did 90% serum for each type. Concentrations of normal serum less than 20% gave more striking reductions in the opsonization of types VI, XVIII, and XXIII than of type XXV. In contrast, type XXV was poorly opsonized in chelated serum at concentrations less than 40%, whereas higher concentrations of chelated and normal serum provided nearly equal opsonizations of this type. Types VI and XXIII were equally well opsonized in chelated and normal serum at concentrations of 20% or more, whereas opsonization of these two types was negligible in concentrations of chelated serum less than 20%. Type XVIII was opsonized less efficiently 5% 10% 20% 40% 90% % Serum Kinetics of alternative pathway opsonization. Experiments were performed to compare the time required for opsonization of pneumococci in normal and MgEGTA-chelated serum. Type XXIII pneumococci were incubated for 5 and 15 min in 20% normal and 20% Mg-EGTA-chelated serum, and the kinetics of phagocytosis were compared (Fig. 3) . After incubation of pneumococci with opsonin, the opsonin was removed by centrifugation before leukocytes were added, thereby preventing any influence the chelator might have on phagocytosis. Opsonization in normal serum was complete within 5 min since there was no difference between the rates of pnagocytosis o0 bactenra o°5 or 15 min. Opsonization in chel; however, was incomplete after 5 Phagocytosis of live, heat-killed, and stored pneumococci. Live and heat-killed pneumococci were opsonized in 20% normal pooled serum, and rates of phagocytosis were compared. The kinetics of phagocytosis of live and heat-killed organisms were similar during the first 30 min of incubation for all four serotypes. Heat-killed pneumococci that had been stored for up to 2 weeks at 4°C retained their type-specific Quellung reaction and the original bacterial concentration. The kinetics of phagocytosis of heat-killed bacteria remained the same during the storage period. In addition, there was no detectable free capsular polysaccharide in the supernatant of heat-killed pneumococcal suspensions when measured by counterimmunoelectrophoresis, which in our laboratory detects as little as 0.15 ,ug of polysaccharide per ml by a standard method (4). Forsgren and Quie used a functional assay for describing serum opsonic activity that depended on intracellular killing as a measure of phagocytosis (8) . This method is indirect, in that some bacterial strains may be killed at a slow rate even though they are opsonized and phagocytized efficiently. Others have used an assay sysOpson1z'ho'n tem that measures the reduction of nitroblue tetrazolium dye by phagocytic cells as an index Opsonizofi'on of phagocytosis (12) . Although this is a functional assay, the end point depends on intracellular metabolic activity of the phagocytes, which may reflect more than pneumococcal opsonization and ingestion.
Recently, methods have been described for measurement of bacterial phagocytosis, utilizing radiolabeled bacteria in functional assay systems pneumoniae (5, 12, 14, 16, 18, 24 (12) . The availability of IgG-deficient serum and C2-deficient serum allowed comparison of the kinetics of phagocytosis in several opsonic sources and permitted the study of opsonic requirements of four pneumococcal serotypes.
All four serotypes were efficiently opsonized in 10% normal serum. Unlike the other serotypes, type XVIII was opsonized in heat-inactivated serum, suggesting that heat-stable serum factors alone were opsonic for this serotype. It is possible that the higher level of type XVIII antibody found in the serum pool employed for these experiments provided these additional heat-stable factors and that type-specific pneumococcal antibody may enhance opsonic activity against the autologous serotype.
All four pneumococcal serotypes were opsonized effectively via the alternative pathway in 90% MgEGTA-chelated serum. Others have also observed efficient alternative pathway opsonization of S. pneumoniae (type XXV) in undiluted human serum (6) and in C4-deficient guinea pig serum (18) . This report illustrates that testing dilutions of chelated and normal sera for opsonic activity more precisely describes differences among serotypes in the efficiency of alternative pathway opsonization. Ten percent chelated and C2-deficient sera provided sufficient alternative pathway opsonic activity only for type XVIII. Although pneumococcal antibody concentration was not determined in the C2-deficient patient, it is possible that type XVIII antibody mediated the enhanced opsonization of this type via the alternative pathway in both sera. Although only type XVIII was opsonized in 10% chelated serum, serum concentration had to be raised to 40% to obtain maximal opsonization of this type via the alternative pathway. In contrast, types VI and XXIII were maximally opsonized via the alternative pathway in 20% chelated serum. Type XXV was most difficult to opsonize via the alternative pathway, since 40% chelated serum was required to obtain maximal alternative-pathway opsonization.
These observations give evidence that pneumococcal types vary in their capacity to activate the alternative pathway. In addition, we observed that opsonization of pneumococci is slower when classical pathway opsonization is blocked by MgEGTA chelation. Root et al. observed a similar lag in alternative pathway opsonization with C4-deficient guinea pig serum (18) . Thus, to evaluate the contribution of the alternative pathway to serum opsonic activity, bacteria must be incubated for sufficient time to allow maximal opsonization in test sera, and it may be necessary to use several dilutions of serum.
Serum deficient in IgG provided opsonic activity for all four pneumococcal serotypes tested, suggesting that complement alone acted as an effective opsonin. We did not, however, exclude any contribution to complement-mediated opsonization made by the small amount of IgM present in this serum.
The results of this study confirm a previous observation of variable opsonic requirements among pneumococcal serotypes (6) . Phagocytosis of radiolabeled opsonized pneumococci in selectively deficient sera demonstrated differences in the relative degree of IgG-independent and alternative-pathway opsonization among four pneumococcal serotypes. There may also be strain differences within particular serotypes. Stephens et al. have shown variability among pneumococcal strains for reactivity with the Fc region of IgG (22) . In addition, Bjorksten et al. have observed strain differences for alternativepathway opsonization among Escherichia coli (3).
The heterogeneity among pneumococcal serotypes for alternative-pathway opsonization may in part explain the predominance of certain types in human infection and may be of importance in determining host response. Others have reported that whole pneumococcal cells and pneumococcal capsular polysaccharide antigen from some types depress C3 levels in vitro by activating the alternative pathway (27) . Winkelstein et al. have shown that reduction in serum C3, produced in C5-deficient mice after treatment with cobra venom factor, significantly reduced serum pneumococcal opsonic activity and increased susceptibility to pneumococcal disease (29) . Pre-opsonization of pneumococci with heat-labile serum factors before inoculation of treated animals prevented the increased susceptibility to infection. Thus, a defect in pneumococcal opsonization may occur during overwhelming pneumococcal infection, with subsequent depletion of C3. This defect may be more striking for those serotypes requiring greater concentrations of alternative-pathway factors for opsonization. The specific pneumococcal opsonic requirements may also explain the predisposition of certain patients, having selective deficiencies of specific antibodies, nonspecific IgM or IgG, complement components, or other serum cofactors, to pneumococcal infection (6, 22, 26) . The precise quantitation provided by these methods will allow measurement of bacterial and host factors that may contribute to host susceptibility to pneumococcal infection.
